4 ms·

> Patents are a different matter. ... patents might be useful in fields where the cost of R&D really is prohibitively high without some reliable way to exploit

by jb613 10y ago

> Patents are a different matter. ... patents might be useful in fields where the cost of R&D really is prohibitively high without some reliable way to exploit any successful projects You seem to be suggesting that cost should be a deciding factor in whether to protect creative work. I disagree that there is a difference here between copyrights and patents. 1) In the tech industry, calculating the "cost" would be anything but straightforward. What would be allowed and what wouldn't? The players are not even comparable - what would stop a large corporation to include their HR, legal departments, and executive team as part of their "R&D costs"? Whereas, a small software startup with 1-3 members getting paid ramen noodles would be hard pressed to properly chalk up a tiny fraction of the costs the large corporation. The large corporation would have no problem showing that "project X cost $1million+ in R&D costs" while the startup would be in $thousands or $tens of thousands. If anything, one might argue that the OPPOSITE of cost would be better indicator - I see more innovation deserving protection from small startups creating things in a weekend than large corporations pushing some new technology developed over years using teams of people and resources. 2) There exist numerous examples where traditional artists create works in relatively short time. How many times have we read about an artist who wrote a song in an afternoon or even an hour? In those cases, the "R&D" costs of creating the song or painting would surely be considered small (if not tiny) when compared to tech R&D. It's contradictory to suggest that creative works protectable by copyrights at times with lower "costs" should be more protectable than tech protectable only by patents.

Silhouette 10y ago
You seem to be suggesting that cost should be a deciding factor in whether to protect creative work. I suppose I am, but only indirectly. I view both copyright and patents as economic instruments. To me, the argument for temporarily restricting freedom to replicate others' work is based on the "greater good" that comes from incentivizing the creation of that work in the first place. However, that argument only makes sense where such an incentive is actually necessary, and to the extent that it is necessary. If something really can be created by someone within a weekend, it is unlikely that the work or insights necessary to create it are particularly unique or valuable. There is little need to incentivize creating or sharing such work with years of exclusive control, because probably many others could (and some will) do the same thing anyway within that time, and granting the exclusivity is just an artificial barrier to any greater progress that any of those creators might then make. On the other hand, maybe identifying a new antibiotic that will save thousands of people from "superbugs" takes several years of expensive laboratory research and then several more years of expensive trials and regulatory approvals, but once identified the marginal cost of manufacture is relatively low and many organisations have the resources to produce the physical product. It seems quite plausible that the research and trials and approvals won't happen in this case unless there is some extra benefit to whoever actually puts in the time and resources to do that work first. Given the likely benefit to society of having access to new antibiotics, I personally don't have a problem with incentivization in this case. (For the same ethical reasons, I also don't have a problem with revoking any exclusivity if whoever holds the rights isn't taking reasonable steps to use them by producing and selling the drug at a fair price; the goal is to promote discovery and availability of a useful drug to those who have a medical need for it, and anyone who isn't actually contributing to that doesn't need special privileges.) Perhaps it would be more accurate to say that I think the cost/benefit should be a deciding factor in which classes of creative work receive these kinds of protections. It's not so much about the absolute cost, but rather whether it's worthwhile for creators to create already, and if not, whether the value to society of having the creation available justifies offering some extra incentive.

by jb613 10y ago

Silhouette 10y ago

You seem to be suggesting that cost should be a deciding factor in whether to protect creative work. I suppose I am, but only indirectly. I view both copyright and patents as economic instruments. To me, the argument for temporarily restricting freedom to replicate others' work is based on the "greater good" that comes from incentivizing the creation of that work in the first place. However, that argument only makes sense where such an incentive is actually necessary, and to the extent that it is necessary. If something really can be created by someone within a weekend, it is unlikely that the work or insights necessary to create it are particularly unique or valuable. There is little need to incentivize creating or sharing such work with years of exclusive control, because probably many others could (and some will) do the same thing anyway within that time, and granting the exclusivity is just an artificial barrier to any greater progress that any of those creators might then make. On the other hand, maybe identifying a new antibiotic that will save thousands of people from "superbugs" takes several years of expensive laboratory research and then several more years of expensive trials and regulatory approvals, but once identified the marginal cost of manufacture is relatively low and many organisations have the resources to produce the physical product. It seems quite plausible that the research and trials and approvals won't happen in this case unless there is some extra benefit to whoever actually puts in the time and resources to do that work first. Given the likely benefit to society of having access to new antibiotics, I personally don't have a problem with incentivization in this case. (For the same ethical reasons, I also don't have a problem with revoking any exclusivity if whoever holds the rights isn't taking reasonable steps to use them by producing and selling the drug at a fair price; the goal is to promote discovery and availability of a useful drug to those who have a medical need for it, and anyone who isn't actually contributing to that doesn't need special privileges.) Perhaps it would be more accurate to say that I think the cost/benefit should be a deciding factor in which classes of creative work receive these kinds of protections. It's not so much about the absolute cost, but rather whether it's worthwhile for creators to create already, and if not, whether the value to society of having the creation available justifies offering some extra incentive.